Division of Vascular Diseases and Surgery

Dr. K Craig Kent is a Professor of Vascular Surgery and Leslie H. and Abigail S. Wexner Dean’s Chair in Medicine. As a vascular surgeon, he specializes in the treatment and prevention of vascular diseases, including aortic aneurysms, thoracic outlet syndrome, and carotid diseases. His basic research interests focus on the molecular and cellular mechanisms underlying vascular disease, with an ultimate goal of developing new therapeutic methods to improve patient care.

  • MD: University of California, San Francisco
  • Residency: University of California, San Francisco, Surgery
  • Fellowship: Brigham & Women’s Hospital, Boston, Vascular Surgery

Research Interests 
  • Restenosis
  • Aneurysm
  • Nanoparticle
  • Biomimetic nanomedicine
  • Vascular devices
  • Drug delivery
  • Controlled release
  • Smooth muscle dysfunction
  • Endothelial dysfunction
  • Outcome research

View PubMed

View Clinical Bio

Current Funding

NIH 1R01HL143469 (Kent, contact PI)
Targeting PERK: An endothelium-protective stent-free strategy for mitigation of intimal hyperplasia after vascular surgery

NIH 1R01HL129785 (Kent, contact PI)
Development of unimolecular nanoparticle-mediated periadventitial drug delivery system for sustained and targeted inhibition of intimal hyperplasia following open vascular reconstruction

NIH R01 HL068673 (Kent, PI)
TGF-beta and Smad3 in intimal hyperplasia after vascular bypass

The Ohio State University Accelerator grant (Kent, PI)
Perivascular Drug Delivery Nanoplatform for Preventing Restenosis After Open Surgery

NCAI-CC Award (Kent, PI)
Pericelle: a nanoparticle based perivascular drug delivery system to prevent stenosis and failure in vascular reconstruction surgeries